Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20041482rdf:typepubmed:Citationlld:pubmed
pubmed-article:20041482lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:20041482lifeskim:mentionsumls-concept:C0024305lld:lifeskim
pubmed-article:20041482lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:20041482lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:20041482lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:20041482lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:20041482lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:20041482lifeskim:mentionsumls-concept:C1705576lld:lifeskim
pubmed-article:20041482lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:20041482pubmed:issue4lld:pubmed
pubmed-article:20041482pubmed:dateCreated2010-2-9lld:pubmed
pubmed-article:20041482pubmed:abstractTextChemotherapy sensitivity, defined simply as at least a partial response to chemotherapy, is an important outcome predictor for non-Hodgkin lymphoma (NHL) patients undergoing reduced-intensity allogeneic hematopoietic stem cell transplantation (allo-HCT). The authors hypothesized that further differentiation of chemotherapy sensitivity by specific response, complete remission (CR) versus partial remission (PR) versus stable disease (SD) versus progression of disease (PD), correlates with post-transplant outcomes.lld:pubmed
pubmed-article:20041482pubmed:languageenglld:pubmed
pubmed-article:20041482pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20041482pubmed:citationSubsetAIMlld:pubmed
pubmed-article:20041482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20041482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20041482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20041482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20041482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20041482pubmed:statusMEDLINElld:pubmed
pubmed-article:20041482pubmed:monthFeblld:pubmed
pubmed-article:20041482pubmed:issn0008-543Xlld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:GressRonald...lld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:SteinbergSeth...lld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:FowlerDaniel...lld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:PollackSeth...lld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:PavleticSteve...lld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:BishopMichael...lld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:OdomJeanneJlld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:DeanRobert...lld:pubmed
pubmed-article:20041482pubmed:authorpubmed-author:SportesClaude...lld:pubmed
pubmed-article:20041482pubmed:issnTypePrintlld:pubmed
pubmed-article:20041482pubmed:day15lld:pubmed
pubmed-article:20041482pubmed:volume116lld:pubmed
pubmed-article:20041482pubmed:ownerNLMlld:pubmed
pubmed-article:20041482pubmed:authorsCompleteYlld:pubmed
pubmed-article:20041482pubmed:pagination852-62lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:meshHeadingpubmed-meshheading:20041482...lld:pubmed
pubmed-article:20041482pubmed:year2010lld:pubmed
pubmed-article:20041482pubmed:articleTitleCorrelation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.lld:pubmed
pubmed-article:20041482pubmed:affiliationExperimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, CRC/Room 4-3152, Bethesda, MD 20892, USA. mbishop@mail.nih.govlld:pubmed
pubmed-article:20041482pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20041482pubmed:publicationTypeResearch Support, N.I.H., Intramurallld:pubmed